vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Black Stone Minerals, L.P. is the larger business by last-quarter revenue ($95.2M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). Black Stone Minerals, L.P. runs the higher net margin — 75.9% vs -70.9%, a 146.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -8.7%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -9.7%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BSM vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $62.1M |
| Net Profit | $72.2M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 78.6% | -9.0% |
| Net Margin | 75.9% | -70.9% |
| Revenue YoY | -8.7% | 8.1% |
| Net Profit YoY | 55.8% | -557.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | $62.1M | ||
| Q3 25 | $105.2M | $52.3M | ||
| Q2 25 | $106.7M | $45.6M | ||
| Q1 25 | $115.3M | $41.5M | ||
| Q4 24 | $104.3M | $57.5M | ||
| Q3 24 | $103.2M | $51.5M | ||
| Q2 24 | $115.2M | $46.6M | ||
| Q1 24 | $116.8M | $44.9M |
| Q4 25 | $72.2M | $-44.1M | ||
| Q3 25 | $91.7M | $-5.5M | ||
| Q2 25 | $120.0M | $-5.6M | ||
| Q1 25 | $15.9M | $-11.4M | ||
| Q4 24 | $46.3M | $9.6M | ||
| Q3 24 | $92.7M | $941.0K | ||
| Q2 24 | $68.3M | $-10.4M | ||
| Q1 24 | $63.9M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | 78.6% | -9.0% | ||
| Q3 25 | 89.5% | -17.6% | ||
| Q2 25 | — | -23.3% | ||
| Q1 25 | 14.9% | -36.1% | ||
| Q4 24 | 45.6% | 5.2% | ||
| Q3 24 | 90.2% | -8.2% | ||
| Q2 24 | 59.5% | -18.3% | ||
| Q1 24 | 54.8% | -23.9% |
| Q4 25 | 75.9% | -70.9% | ||
| Q3 25 | 87.2% | -10.5% | ||
| Q2 25 | 112.5% | -12.2% | ||
| Q1 25 | 13.8% | -27.5% | ||
| Q4 24 | 44.4% | 16.8% | ||
| Q3 24 | 89.9% | 1.8% | ||
| Q2 24 | 59.3% | -22.4% | ||
| Q1 24 | 54.7% | -13.8% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $341.7M |
| Total Assets | $1.3B | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $90.9M | ||
| Q3 25 | $2.9M | $93.3M | ||
| Q2 25 | $2.5M | $75.5M | ||
| Q1 25 | $2.4M | $95.3M | ||
| Q4 24 | $2.5M | $98.7M | ||
| Q3 24 | $21.0M | $162.3M | ||
| Q2 24 | $26.7M | $177.9M | ||
| Q1 24 | $40.5M | $168.8M |
| Q4 25 | — | $341.7M | ||
| Q3 25 | — | $378.6M | ||
| Q2 25 | — | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | — | $395.7M | ||
| Q3 24 | — | $385.5M | ||
| Q2 24 | — | $389.1M | ||
| Q1 24 | — | $392.6M |
| Q4 25 | $1.3B | $461.5M | ||
| Q3 25 | $1.3B | $494.9M | ||
| Q2 25 | $1.3B | $493.3M | ||
| Q1 25 | $1.2B | $482.6M | ||
| Q4 24 | $1.2B | $499.5M | ||
| Q3 24 | $1.2B | $491.2M | ||
| Q2 24 | $1.2B | $483.7M | ||
| Q1 24 | $1.2B | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 0.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | $-771.0K | ||
| Q3 25 | $99.8M | $-3.9M | ||
| Q2 25 | $80.5M | $108.0K | ||
| Q1 25 | $64.8M | $-125.0K | ||
| Q4 24 | $91.0M | $2.0M | ||
| Q3 24 | $93.2M | $13.2M | ||
| Q2 24 | $100.4M | $6.2M | ||
| Q1 24 | $104.5M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 4.07× | — | ||
| Q4 24 | 1.96× | 0.21× | ||
| Q3 24 | 1.01× | 14.05× | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
